TempoSmart v1.1
by Welldoc
TempoSmart v1.1 is a home pharmaceutical management support software (FDA product code LNX, Medical Computers And Software) made by Welldoc, cleared under FDA 510(k) K190013 on 4 Nov 2019 and listed in FDA GUDID since 7 Aug 2023 (UDI-DI B553TEMPOSMART110), active as of 23 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | NumberB553TEMPOSMART110 | Date7 Aug 2023 | StatusListed |
| United States | FDA 510(k)SESE | NumberK190013 | Date4 Nov 2019 | StatusActive |
Official records
- FDA 510(k) database K190013
From the FDA record
- Device description
- TempoSmart™ is a Software as a Medical Device (SaMD) intended to be used by healthcare providers (HCPs) and their patients – aged 18 years and older - who have type 1 or type 2 diabetes. TempoSmart is intended to assist patients in managing their diabetes with guidance from their providers.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K190013 decided 4 Nov 2019 Active
- FDA GUDID UDI-DI B553TEMPOSMART110 listed 7 Aug 2023 Listed
Timeline
- Cleared FDA 510(k) K190013
- Listed FDA GUDID B553TEMPOSMART110
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- TempoSmart
- Generic name
- Home pharmaceutical management support software
- Model / reference
- v1.1
- Primary DI / UDI-DI
- B553TEMPOSMART110
- 510(k) Number
- FDA product code
- LNX
- GMDN term
- Home pharmaceutical management support software
- GUDID distribution status
- In Commercial Distribution